Search Results

S100A1: Structure, Function, and Therapeutic Potential

Authors: Wright, Nathan T.; Cannon, Brian R.; Zimmer, Danna B.; Weber, David J.

Source: Current Chemical Biology, Volume 3, Number 2, May 2009 , pp. 138-145(8)

Publisher: Bentham Science Publishers

Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology

Authors: Liu, R.; Zhou, X.-W.; Tanila, H.; Bjorkdahl, C.; Wang, J.-Z.; Guan, Z.-Z.; Cao, Y.; Gustafsson, J.-Å.; Winblad, B.; Pei, J.-J.

Source: Journal of Cellular and Molecular Medicine, Volume 12, Number 1, January/February 2008 , pp. 241-257(17)

Publisher: Blackwell Publishing

A Gne knockout mouse expressing human V572L mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy

Authors: Malicdan, May Christine V.; Noguchi, Satoru; Nonaka, Ikuya; Hayashi, Yukiko K.; Nishino, Ichizo

Source: Human Molecular Genetics, Volume 16, Number 2, 15 January 2007 , pp. 115-128(14)

Publisher: Oxford University Press

Vasopressin 1a receptor knockout mice have a subtle olfactory deficit but normal aggression

Authors: Wersinger; Caldwell; Martinez; Gold; Hu; Young

Source: Genes, Brain & Behavior, Volume 6, Number 6, August 2007 , pp. 540-551(12)

Publisher: Blackwell Publishing

p35/Cyclin-dependent kinase 5 is required for protection against β-amyloid-induced cell death but not tau phosphorylation by ceramide

Authors: Seyb, Kathleen; Ansar, Sabah; Li, Guibin; Bean, Jennifer; Michaelis, Mary; Dobrowsky, Rick

Source: Journal of Molecular Neuroscience, Volume 31, Number 1, February 2007 , pp. 23-35(13)

Publisher: Humana Press

Therapeutic Opportunities in Alzheimer Disease: One for all or all for One?

Authors: Marlatt, Michael W.; Webber, Kate M.; Moreira, Paula I.; Lee, Hyoung-gon; Casadesus, Gemma; Honda, Kazuhiro; Zhu, Xiongwei; Perry, George; Smith, Mark A.

Source: Current Medicinal Chemistry, Volume 12, Number 10, May 2005 , pp. 1137-1147(11)

Publisher: Bentham Science Publishers

Development of a High Throughput Drug Screening Assay for the Detection of Changes in Tau Levels - Proof of Concept with HSP90 inhibitors

Authors: Dickey, Chad A.; Eriksen, Jason; Kamal, Adeela; Burrows, Francis; Kasibhatla, Srinivas; Eckman, Christopher B.; Hutton, Mike; Petrucelli, Leonard

Source: Current Alzheimer Research, Volume 2, Number 2, April 2005 , pp. 231-238(8)

Publisher: Bentham Science Publishers

Taurine and Its Chloramine: Modulators of Immunity: Special Issue Dedicated to Dr. Herminia Pasantes-Morales

Authors: Schuller-Levis G.B.; Park E.

Source: Neurochemical Research, Volume 29, Number 1, January 2004 , pp. 117-126(10)

Publisher: Springer

Circadian rhythms of activity and drinking in mice lacking angiotensin II 1A receptors

Authors: Mistlberger R.E.; Antle M.C.; Oliverio M.I.; Coffman T.M.; Morris M.

Source: Physiology and Behavior, Volume 74, Number 4, 12 November 2001 , pp. 457-464(8)

Publisher: Elsevier

Delayed neurite extension in primary hippocampal cultures from tau knockout mice

Authors: Dawson D.N.; Ferreira A.; Eyster M.V.; Scorzafava M.V.; Herbstreith M.V.; Vitek M.P.

Source: Neurobiology of Aging, Volume 21, Supplement 1, May 2000 , pp. 88-88(1)

Publisher: Elsevier

Isoaspartate Formation and Neurodegeneration in Alzheimer's Disease

Authors: Shimizu T.; Watanabe A.; Ogawara M.; Mori H.; Shirasawa T.

Source: Archives of Biochemistry and Biophysics, Volume 381, Number 2, 15 September 2000 , pp. 225-234(10)

Publisher: Elsevier

Isoaspartate Formation and Neurodegeneration in Alzheimer's Disease

Authors: Shimizu T.; Watanabe A.; Ogawara M.; Mori H.; Shirasawa T.

Source: Archives of Biochemistry and Biophysics, Volume 381, Number 2, September 2000 , pp. 225-234(10)

Publisher: Academic Press